Turn Therapeutics (TTRX) Non Operating Income (2024 - 2026)

Turn Therapeutics' quarterly Non Operating Income came in at $275171.0 in Q1 2026, up 387.46% year-on-year from $56450.0 in Q1 2025, and down 76.35% quarter-over-quarter from $1.2 million in Q4 2025.

Turn Therapeutics has reported Non Operating Income for 3 years, with the latest figure at $275171.0 in Q1 2026.

  • For the quarter ending Q1 2026, Non Operating Income rose 387.46% year-over-year to $275171.0; the trailing twelve-month figure through Mar 2026 stood at $1.5 million (changed N/A YoY), and the FY2025 full-year result was $1.3 million, up 54.57% from the prior year.
  • Non Operating Income for Q1 2026 stood at $275171.0, down from $1.2 million in the prior quarter.
  • The five-year high for Non Operating Income was $1.2 million in Q4 2025, with the low at $6550.0 in Q3 2024.
  • Average Non Operating Income over 3 years is $392543.7, with a median of $165810.5 recorded in 2025.
  • Year-over-year, Non Operating Income jumped 37.85% in 2025 and jumped 387.46% in 2026.
  • Tracing TTRX's Non Operating Income over 3 years: stood at $844102.0 in 2024, then jumped by 37.85% to $1.2 million in 2025, then sank by 76.35% to $275171.0 in 2026.
  • The last three Non Operating Income figures came in at $275171.0 (Q1 2026), $1.2 million (Q4 2025), and $9371.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 444,000.00
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 201.20 Mn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -46.98 Mn
10 Turn Therapeutics 188.06 Mn 188.06 Mn - 275,171.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 275,171.00
Dec 31, 2025 1.16 Mn
Sep 30, 2025 9,371.00
Mar 31, 2025 56,450.00
Dec 31, 2024 844,102.00
Sep 30, 2024 6,550.00